강가원 프로필 사진

강가원

Kang, Ka-Won
Scopus ORCID

자료 필터

자료유형

발행연도

2007 ~ 2026
2007 2026

키워드

언어

전체 166건 중 11번부터 20번까지의 결과를 표시합니다.

2025
Article

Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions

  • Jung, Sung-Hoon ; 
  • Koh, Youngil ; 
  • Kim, Min Kyoung ; 
  • Kim, Jin Seok ; 
  • Moon, Joon Ho ; 
  • ... Kang, Ka-Won ; 
  • ... Kim, Dae Sik ; 
  • 외 37명
  • 2025-12
  • Blood Research
  • 대한혈액학회
Conference

Poseltinib combined with rituximab and lenalidomide is a promising chemotherapy-free therapy in relapsed or refractory primary central nervous system lymphoma

  • Kim, Dong Hyun ; 
  • An, Sanyeowool ; 
  • Kang, Ka-Won ; 
  • Yoon, Sang Eun ; 
  • Kim, Seok Jin ; 
  • 외 3명
  • 2025-12
  • 네덜란드
Conference

Treatment patterns and survival outcomes in patients with Mantle Cell Lymphoma: Interim report of the Asia-Pacific multinational prospective registry study

  • Yoon, Dok Hyun ; 
  • Cho, Hyungwoo ; 
  • Chan, Jason Yongsheng ; 
  • Kim, Dajung ; 
  • Kato, Koji ; 
  • ... Kang, Ka-Won ; 
  • 외 19명
  • 2025-11-03
  • 네덜란드
Article

Impact of Cell-of-Origin and MYC/BCL2 Status on the Risk of Central Nervous System Relapse in Primary Breast Diffuse Large B-Cell Lymphoma

  • Lee, Chang-Hoon ; 
  • Song, Ga-Young ; 
  • Yhim, Ho-Young ; 
  • Yoon, Dok Hyun ; 
  • Jang, Kyu Yun ; 
  • ... Kang, Ka-Won ; 
  • 외 14명
  • 2025-11
  • Cancer Research and Treatment
  • 대한암학회
Article

Prognostic Factors for Relapse and the Role of Maintenance Therapy in Acute Promyelocytic Leukemia: A Real-World Multicenter Study in Korea

  • 2025-11
  • Cancer Research and Treatment
  • 대한암학회
Article

Chemotherapy-Free Salvage Therapy with Rituximab, Lenalidomide, and Poseltinib in Relapsed or Refractory Primary Central Nervous System Lymphoma: A Multi-Center, Phase II Study

  • Kim, Dong Hyun ; 
  • An, Sanyeowool ; 
  • Ahn, Hongyul ; 
  • Song, Han ; 
  • Kang, Ka-Won ; 
  • 외 5명
  • 2025-11
  • Cancer Research and Treatment
  • 대한암학회